NSI N.V. NEW EO 3,68/ NL0012365084 /
2024-05-31 8:15:37 AM | Chg. +0.580 | Volume | Bid9:57:08 PM | Ask9:57:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
19.780EUR | +3.02% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 381.79 mill.EUR | 11.03% | 3.16 |
GlobeNewswire
1:00 AM
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
12:43 AM
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
06-02
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
06-02
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
06-02
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
06-02
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...